https://www.selleckchem.com/products/vx-11e.html
Bladder anticholinergics are the most widely used drugs to treat overactive bladder (OA but can contribute to cumulative anticholinergic burden, which may be associated with adverse outcomes. This study aimed to evaluate the association between cumulative anticholinergic burden and healthcare resource utilization (HRU) and costs in older adults with OAB. This was a retrospective, observational study that used data from the UK Clinical Practice Research Datalink (CPRD) GOLD database. Participants were aged ≥65 years with ≥3years of cont
Aimer
Commentaire
Partagez
